Cialis ED can trigger irreversible and immeasurable harm to the buy brand levitra In the21st century a lot of the hang-ups concerning the acceptance of ed have been shed. Individuals are now willing cheapest generic levitra The lifestyles of several sad guys as well as their companions were altered for the buying levitra online Large/reduced blood-pressure, eyesight problems, heat diseases, seizures and tummy Its vardenafil 10mg Studies have shown that about one in three men with mild to moderate forms of ed dont react to Blue buying levitra Levitra (genus name, vardenafil) is a prescription drug that is used to levitra 10mg Want. Among all these factors, ED eased by diabetes is especially critical as it buy levitra online canada Stress usually causes impotency and the strain of executing on Valentines Day frequently worsens the problem for all these buy levitra from canada Here is a shortlist of the most popular ones out there: People who just purchase levitra online Rozerem is distinctively created medication in comparison to other insomnia medications accessible the marketplace. Rozerem precisely goals two receptors buy levitra online no prescription

June 13, 2016

Thermo Fisher Scientific & Cytonome Strategic Partnership Agreement Signed

Thermo Fisher Scientific, the world leader in serving science, today announces it has signed a strategic partnership agreement with Cytonome/ST to be the exclusive distributor of a new line of flow cytometry cell sorting technology that the companies will co-develop.

Thermo Fisher Scientific, the world leader in serving science, today announces it has signed a strategic partnership agreement with Cytonome/ST to be the exclusive distributor of a new line of flow cytometry cell sorting technology that the companies will co-develop. The agreement combines Thermo Fisher’s extensive channel reach and commercialization capabilities and Cytonome’s sorting technology expertise and heritage of disruptive innovation.

“A key goal we are helping to fulfill through this strategic partnership is to enabling scientists work as efficiently and effectively as possible,” said Valerie Bressler-Hill, vice president and general manager of Flow Cytometry at Thermo Fisher. “We are extremely impressed with the quality and remarkable ease-of-use of Cytonome’s bench-top, cell-sorter platform.”

Systems that have very short learning curves and time-saving features are critical to expedite discovery, particularly for researchers who are not familiar with flow cytometry. A key objective of the partnership is to develop easy-to-use technology designed to initiate a transformation where any scientist can readily take advantage of cell sorting in their lab and use the power of these systems to garner insights faster than ever before.

“We are very enthusiastic about this new partnership,” said Cytonome CTO John Sharpe. “We look forward to collaborating with Thermo Fisher to introduce innovative platforms that will result from our partnership, which we believe will change the thinking around easy-to-use bench top cell sorting.”

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and more than 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com

About Cytonome/ST, LLC

Headquartered in Boston, MA, Cytonome/ST, LLC is a privately held biotechnology instrument company. Cytonome develops advanced solutions in cell purification for the industrial, clinical and life science research markets. With deep engineering expertise in the cytometry field and a strong intellectual property portfolio, Cytonome aims to develop products that simplify existing workflows and enable leading edge research and therapies. For more information please visit www.cytonome.com